Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Multicolor flow cytometric analysis of FoxP3 expressed in human lymphocytes. Human peripheral blood mononuclear cells (PBMC) were stained with FITC Mouse Anti-Human CD4 (Cat. No. 555346/561842/561005) and APC anti-Human CD25 (Cat. No. 555434/560987) antibodies. The cells were then fixed and permeabilized (see Recommended Assay Procedure) and stained with BD Horizon™ PE-CF594 Mouse Anti-Human FoxP3 antibody (Cat No. 562421). Two-color flow cytometric dot plots show the correlated expression of either CD25 (Left Panel) or CD4 (Right Panel) versus FoxP3 derived from gated events with the light scattering characteristics of intact lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometry System.
Multicolor flow cytometric analysis of FoxP3 expressed in human lymphocytes. Human peripheral blood mononuclear cells (PBMC) were stained with FITC Mouse Anti-Human CD4 (Cat. No. 555346/561842/561005) and APC anti-Human CD25 (Cat. No. 555434/560987) antibodies. The cells were then fixed and permeabilized (see Recommended Assay Procedure) and stained with BD Horizon™ PE-CF594 Mouse Anti-Human FoxP3 antibody (Cat No. 562421). Two-color flow cytometric dot plots show the correlated expression of either CD25 (Left Panel) or CD4 (Right Panel) versus FoxP3 derived from gated events with the light scattering characteristics of intact lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometry System.
Multicolor flow cytometric analysis of FoxP3 expressed in human lymphocytes. Human peripheral blood mononuclear cells (PBMC) were stained with FITC Mouse Anti-Human CD4 (Cat. No. 555346/561842/561005) and APC anti-Human CD25 (Cat. No. 555434/560987) antibodies. The cells were then fixed and permeabilized (see Recommended Assay Procedure) and stained with BD Horizon™ PE-CF594 Mouse Anti-Human FoxP3 antibody (Cat No. 562421). Two-color flow cytometric dot plots show the correlated expression of either CD25 (Left Panel) or CD4 (Right Panel) versus FoxP3 derived from gated events with the light scattering characteristics of intact lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometry System.
Multicolor flow cytometric analysis of FoxP3 expressed in human lymphocytes. Human peripheral blood mononuclear cells (PBMC) were stained with FITC Mouse Anti-Human CD4 (Cat. No. 555346/561842/561005) and APC anti-Human CD25 (Cat. No. 555434/560987) antibodies. The cells were then fixed and permeabilized (see Recommended Assay Procedure) and stained with BD Horizon™ PE-CF594 Mouse Anti-Human FoxP3 antibody (Cat No. 562421). Two-color flow cytometric dot plots show the correlated expression of either CD25 (Left Panel) or CD4 (Right Panel) versus FoxP3 derived from gated events with the light scattering characteristics of intact lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometry System.
Multicolor flow cytometric analysis of FoxP3 expressed in human lymphocytes. Human peripheral blood mononuclear cells (PBMC) were stained with FITC Mouse Anti-Human CD4 (Cat. No. 555346/561842/561005) and APC anti-Human CD25 (Cat. No. 555434/560987) antibodies. The cells were then fixed and permeabilized (see Recommended Assay Procedure) and stained with BD Horizon™ PE-CF594 Mouse Anti-Human FoxP3 antibody (Cat No. 562421). Two-color flow cytometric dot plots show the correlated expression of either CD25 (Left Panel) or CD4 (Right Panel) versus FoxP3 derived from gated events with the light scattering characteristics of intact lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometry System.
Multicolor flow cytometric analysis of FoxP3 expressed in human lymphocytes. Human peripheral blood mononuclear cells (PBMC) were stained with FITC Mouse Anti-Human CD4 (Cat. No. 555346/561842/561005) and APC anti-Human CD25 (Cat. No. 555434/560987) antibodies. The cells were then fixed and permeabilized (see Recommended Assay Procedure) and stained with BD Horizon™ PE-CF594 Mouse Anti-Human FoxP3 antibody (Cat No. 562421). Two-color flow cytometric dot plots show the correlated expression of either CD25 (Left Panel) or CD4 (Right Panel) versus FoxP3 derived from gated events with the light scattering characteristics of intact lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometry System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Cell Preparation and Staining Procedures for Conjugated Anti-Human FoxP3 Antibody
1. Bring the buffers to RT before use. Prepare working solutions of the BD Pharmingen™ Human FoxP3 Buffer Set (Cat. No. 560098) (For the buffer preparation, please see TDS Cat. No. 560098 buffer instructions for details).
2. Prepare human PBMC. Dilute the cells with BD Pharmingen Stain Buffer (FBS)* to 1X10^7 cells/ml.
3. Pipette appropriate amount of surface staining reagent to the bottom of each 12 x 75 mm tube.
4. Add 100 µl of cells per tube, vortex, incubate for 20 minutes at RT, protected from light.
5. Add 2 ml of wash buffer. Centrifuge 250 x g for 10 minutes and remove wash buffer.
6. To fix the cells, gently resuspend cell pellet in residual volume of wash buffer and then add 2 ml of 1x Human FoxP3 Buffer A. Vortex. Incubate for 10 minutes at RT in the dark.
7. Centrifuge 500 x g for 5 minutes, and remove fixative. Caution: Be aware the pellet is buoyant.
8. To wash cells, resuspend each cell pellet in 2 ml of BD Pharmingen Stain Buffer (FBS)*, and centrifuge 500 x g for 5 minutes. Remove wash buffer.
9. To permeabilize the cells, gently resuspend the cell pellet in residual volume of wash buffer and then add 0.5 ml of 1x working solution Human FoxP3 Buffer C to each tube. Vortex. Incubate for 30 minutes at RT, protected from light.
10. To wash cells, add 2 ml of BD Pharmingen Stain Buffer (FBS)* to each tube, centrifuge 500 x g for 5 minutes at RT. Remove buffer and repeat wash step. Remove buffer.
11. Add conjugated FoxP3 antibody at appropriate concentrations to resuspend the cell pellet. Gently shake or vortex.
12. Incubate for 30 minutes in the dark at RT.
13. Repeat wash step #10.
14. Resuspend in wash buffer and analyze cells by flow cytometry immediately.
Optional: Add 300 µl of 1% formaldehyde in 1x PBS and store at 4°C. Analyze cells within 24 hours.
* Recommend i) use of BD Pharmingen™ Stain Buffer (FBS; Cat No. 554656) for all wash steps and covering tubes during incubation steps with caps or Parafilm M® and ii) optimal forward and side light scatter voltages to distinguish lymphocytes from debris, red cell ghosts and/or platelets before acquisition.
** Acquire at least 15,000 to 25,000 CD4 positive lymphocytes.
The 259D/C7 monoclonal antibody specifically recognizes human Forkhead box protein P3 (FoxP3) that is also known as Scurfin. FoxP3 is encoded by FOXP3 (Forkhead box P3), likewise known as IPEX (Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked) and JM2, that belongs to the forkhead/winged-helix family of transcriptional regulators. FoxP3 is expressed in CD4+ regulatory T cells (Treg) and represents a specific marker for these cells. Flow cytometric analyses have shown that FoxP3 is expressed by the majority of CD4+CD25+high T cells in peripheral blood while less than half of the CD4+CD25+intermediate cell population are FoxP3 positive. Approximately 5-10% of peripheral CD4+ cells are CD4+CD25+ T regulatory cells. T regulatory cells are thought to play a critical role in the regulation of T cell-mediated immunity and to protect against autoimmunity by suppressing the proliferation and cytokine production of other T cells. In support of this hypothesis, it has been found that Foxp3 is mutated in Scurfy (sf) mice that have defective T cell tolerance leading to an X-linked lymphoproliferative disease. The 259D/C7 antibody recognizes all currently-identified isoforms of human FoxP3 and is crossreactive with FoxP3 from Cynomolgus, Rhesus and Baboon primates.
This antibody is conjugated to BD Horizon™ PE-CF594, which has been developed exclusively by BD Biosciences as a better alternative to PE-Texas Red®. PE-CF594 excites and emits at similar wavelengths to PE-Texas Red® yet exhibits improved brightness and spectral characteristics. Due to PE having maximal absorption peaks at 496 nm and 564 nm, PE-CF594 can be excited by the blue (488-nm), green (532-nm) and yellow-green (561-nm) lasers and can be detected with the same filter set as PE-Texas Red® (eg 610/20-nm filter).
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.